GoodRx Holdings, Inc. (GDRX) stock
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)
Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –
GoodRx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
GoodRx's pe ratio was 91.3× on Nov 11, 2026, against 31.2× a year earlier. Over the last 3 years it ranged from 20.8× to 555.5×, with a median of 87.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 91.3× | +61.1 |
| 2025 | Dec 31, 2025 | 30.1× | −119.9 |
| 2024 | Jan 31, 2024 | 150.0× | −17.5 |
| 2023 | Dec 29, 2023 | 167.5× | −388.0 |
| 2021 | Jan 29, 2021 | 555.5× | +74.8 |
| 2020 | Dec 31, 2020 | 480.6× | – |
See a number that looks wrong?